MEDICALLY REVIEWED

FDA Approves Omisirge Cell Therapy to Reduce Infection Risk in Patients with Hematologic Malignancies

Chemotherapy
Omisirge is used in adults and children aged 12+ for cord blood transplant after myeloablative conditioning in hematologic malignancies.

Log In or Register as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

Research team members from Asst Prof Leong Sai Mun’s lab, discussing experimental data for their study on cancer cell altruism. (From left to right: PhD student Poon Kok Siong, Dr Muhammad Sufyan, Dr Tan Yuen Peng, Dr Leong Sai Mun) Breast cancer6
New Study Unveils Altruistic Behaviour of Cancer Cells in Breast Cancer Treatment Resistance

A team from the NUS Centre for Cancer Research (N2CR) and the Department of Pathology at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), has made a significant discovery in the understanding of breast cancer’s resistance to chemotherapy. The study, led by Research Assistant Professor Leong Sai Mun, spanned over a decade and examined a large cohort of breast cancer patients to understand the dynamics of cancer cell survival post-chemotherapy.

Read More »
Dr Sathindren Santhirathelagan sleep deprivation
Sleep Deprivation And Cardiovascular Health : A Silent Epidemic Among Malaysians

A recent study shows that delaying sleep by just 90 minutes each night damages blood vessels, contributing to the development of cardiovascular diseases. A study conducted in the University of Columbia recently showed that mild sleep restriction among female individuals causes an increase in oxidative stress in blood vessels. It is the first direct evidence linking mild, chronic sleep deficits to causing heart disease.

Read More »

Have a health question?

Share it with us and get it answered by a doctor!